Drawing for ONCO INVENT

USPTO serial 79219135

ONCO INVENT

Reviewed by CopyMark Law Group

Reg. 5567673Status 707Registered
Filing date
Status date
Registration date
Sep 25, 2018
Examiner
MICHELI, ANGELA M
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ONCO INVENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Bondi

Michael Bondi Spencer Fane LLP100 South Fifth Street, Suite 2500Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the treatment of cancer; [ sanitary preparations for medical purposes; dietary supplements for humans and animals; medical plasters, materials for dressings in the form of wound dressing and bandages for dressing; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; ] preparations for treatment of cancer; preparations for treatment of tumors; therapeutic preparations for treatment of micro metastases; anti-cancer preparations for injections; radioactive preparations for radiation treatment; radioactive medicines for cancer treatment [ ; diagnostic preparations for medical purposes ]ACTIVE—
010[ Surgical instruments, medical apparatus and instruments for use in cancer treatment; artificial limbs, eyes and teeth; suture materials; apparatus and instruments for injection of pharmaceuticals; apparatus and instruments for dosing of pharmaceuticals ]SECTION 71 - CANCELLED—
042Scientific and technological services, namely, research and design in the field of cancer treatment; Industrial research in the field of cancer treatment; [ design and development of computer hardware and software; ] research and development of pharmaceuticals, preparations for cancer treatment, preparations for treatment of tumors, therapeutic preparations for treatment of micro metastases, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals and diagnostic preparations [ ; design and development of medical diagnostical equipment; research and development of medical diagnostic preparations; design and development of medical technique; research and development for the pharmaceutical industry; consulting services in the field of pharmaceutical research and development ]ACTIVE—
044[ Medical services; veterinary services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 1, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 26, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 1, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 1, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jul 1, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 1, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jun 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 25, 2025ES71TEAS SECTION 71 RECEIVED—
Sep 25, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 10, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 10, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 10, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 10, 2019FIMPFINAL DISPOSITION PROCESSED—
Dec 25, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 25, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 10, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 10, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 4, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 4, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 20, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 4, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jun 4, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 4, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 4, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2017RFNTREFUSAL PROCESSED BY IB—
Nov 13, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 13, 2017RFRRREFUSAL PROCESSED BY MPU—
Nov 3, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 2, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 26, 2017DOCKASSIGNED TO EXAMINER—
Oct 26, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance